These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15115417)

  • 21. Treatment in thrombotic antiphospholipid syndrome: a review.
    Vadgama TS; Smith A; Bertolaccini ML
    Lupus; 2019 Sep; 28(10):1181-1188. PubMed ID: 31345117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.
    Joshi A; Hong J; Siva C
    Clin Med Res; 2017 Jun; 15(1-2):41-44. PubMed ID: 28751467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
    Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity and duration of oral anticoagulation in antiphospholipid antibody associated thrombosis.
    Hunt BJ; Khamashta MA
    J Rheumatol; 2002 Nov; 29(11):2468; author reply 2468-70. PubMed ID: 12415613
    [No Abstract]   [Full Text] [Related]  

  • 29. Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome.
    Nakajima T; Enomoto Y; Ishigaki M; Hasegawa Y; Tokunaga C; Hiramatsu Y; Sakamoto H
    J Card Surg; 2017 Oct; 32(10):633-635. PubMed ID: 28944492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibody syndrome: further evidence to guide clinical practice?
    Crowther MA
    J Rheumatol; 2004 Aug; 31(8):1474-5. PubMed ID: 15290722
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
    Meroni PL; Moia M; Derksen RH; Tincani A; McIntyre JA; Arnout JM; Koike T; Piette JC; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):504-7. PubMed ID: 12892388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation in the antiphospholipid syndrome.
    Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
    Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.
    Crowther MA
    Cleve Clin J Med; 2005 Mar; 72(3):245-9. PubMed ID: 15825803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of a randomized clinical trial for the prevention of recurrent thrombosis in the antiphospholipid syndrome: the WAPS project. Provisional Steering Committee of the Warfarin in Antiphospholipid Syndrome (WAPS) Study.
    Finazzi G; Barbui T
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():38-41. PubMed ID: 8952760
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transient elevation of the number of microembolic signal in a patient with primary antiphospholipid antibody syndrome].
    Sakai K; Nakajima T; Fukuhara N
    No To Shinkei; 2006 May; 58(5):439-42. PubMed ID: 16780057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuations of international normalized ratio in patients treated with oral warfarin therapy in Sneddon's syndrome.
    Lousa M; Gobernado JM; Pardo A
    Eur J Neurol; 1999 Mar; 6(2):255. PubMed ID: 10053242
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
    Khamashta MA
    Lupus; 1998; 7 Suppl 2():S162-5. PubMed ID: 9814696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis in the antiphospholipid-antibody syndrome.
    Slivka A; Walz E
    N Engl J Med; 1995 Sep; 333(10):665-6; author reply 666-7. PubMed ID: 7637736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.